Inventor
YUEN PO-WAI
CN62 patents
⚠️ This page may combine multiple inventors who share the name “YUEN PO-WAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NORTHWESTERN
15 patentsUS6028214AFeb 22, 2000
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN114 citations99
US6117906ASep 12, 2000
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN98 citations98
US5563175AOct 8, 1996
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN215 citations98
US5608090AMar 4, 1997
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN21 citations96
US5599973AFeb 4, 1997
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN90 citations96
US6359169B1Mar 19, 2002
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN33 citations95
US5847151ADec 8, 1998
Gaba and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN19 citations95
US5710304AJan 20, 1998
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN26 citations95
US5684189ANov 4, 1997
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN21 citations95
US6342529B1Jan 29, 2002
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN7 citations82
US6291526B1Sep 18, 2001
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN7 citations82
US6140366AOct 31, 2000
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN7 citations82
US6255345B1Jul 3, 2001
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN8 citations81
US6525096B1Feb 25, 2003
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN2 citations74
US6414024B1Jul 2, 2002
GABA and L-glutamic acid analogs for antiseizure treatment
UNIV NORTHWESTERN1 citations62
WARNER LAMBERT CO
13 patentsUS6124323ASep 26, 2000
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO54 citations96
US5767129AJun 16, 1998
Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
WARNER LAMBERT CO21 citations93
US5145845ASep 8, 1992
Substituted 2-carboxylindoles having pharmaceutical activity
WARNER LAMBERT CO39 citations93
US6635673B1Oct 21, 2003
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
WARNER LAMBERT CO14 citations92
US5760048AJun 2, 1998
Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
WARNER LAMBERT CO25 citations92
US5284862AFeb 8, 1994
Derivatives of 2-carboxyindoles having pharmaceutical activity
WARNER LAMBERT CO21 citations92
US6642398B2Nov 4, 2003
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
WARNER LAMBERT CO45 citations90
US5554767ASep 10, 1996
Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
WARNER LAMBERT CO36 citations88
US5932573AAug 3, 1999
Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
WARNER LAMBERT CO14 citations74
US7122678B2Oct 17, 2006
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
WARNER LAMBERT CO8 citations73
US7423054B2Sep 9, 2008
Therapeutic pyrazolo[3,4-b]pyridines and indazoles
WARNER LAMBERT CO4 citations63
US5679680AOct 21, 1997
α-substituted hydrazides having calpain inhibitory activity
WARNER LAMBERT CO4 citations62
US5874426AFeb 23, 1999
Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
WARNER LAMBERT CO4 citations61
GENENTECH INC
9 patentsUS9822129B2Nov 21, 2017
Amido spirocyclic amide and sulfonamide derivatives
GENENTECH INC26 citations93
US9605005B2Mar 28, 2017
Alkynyl alcohols and methods of use
GENENTECH INC5 citations72
US11603373B2Mar 14, 2023
TDO2 and IDO1 inhibitors
GENENTECH INC2 citations71
US9346815B2May 24, 2016
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof
GENENTECH INC5 citations71
US10800780B2Oct 13, 2020
TDO2 Inhibitors
GENENTECH INC4 citations70
US11236046B2Feb 1, 2022
Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators
GENENTECH INC0 citations61
US11155557B2Oct 26, 2021
Pyrazolopyrimidine compounds and methods of use thereof
GENENTECH INC1 citations61
US12583858B2Mar 24, 2026
TDO2 inhibitors
GENENTECH INC0 citations59
US11649241B2May 16, 2023
Pyrazolochlorophenyl compounds, compositions and methods of use thereof
GENENTECH INC0 citations59
FORMA TM LLC
7 patentsUS10772874B2Sep 15, 2020
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC6 citations83
US10647695B2May 12, 2020
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC5 citations83
US10456382B2Oct 29, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC7 citations83
US10329275B2Jun 25, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC8 citations83
US10272072B2Apr 30, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC11 citations83
US10730889B2Aug 4, 2020
Amido spirocyclic amide and sulfonamide derivatives
FORMA TM LLC6 citations82
US10696692B2Jun 30, 2020
Amido-benzyl sulfone and sulfoxide derivates
FORMA TM LLC6 citations72
VALO HEALTH INC
4 patentsUS11279687B2Mar 22, 2022
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC2 citations73
US11547701B2Jan 10, 2023
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC2 citations72
US11485745B2Nov 1, 2022
Amido spirocyclic amide and sulfonamide derivatives
VALO HEALTH INC2 citations72
US12336981B2Jun 24, 2025
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC0 citations62
BAIR KENNETH W
1 patentPFIZER
1 patentShowing the top 50 of 62 patents by PatentIndex Score.